Transitioning to inhaled medication
BreathEazy Colour Logo
Written by Jon Slattery
16th June 2020

Most patients that are diagnosed with allergic or inflammatory airway disease will be initially stabilised on injectable or oral medication. Whilst this usually leads to a rapid reduction of clinical symptoms there are notable draw backs to their long term usage.

Corticosteroids given by tablet or injection get distributed around the whole body and so affect every organ system. Over time this may lead to significant side effects such as diabetes or increased risk of infections.

Corticosteroids given by the inhaled route target just the lungs, exactly where they are needed, with minimal side effects.

Transitioning from oral to inhaled steroids may seems like a daunting prospect for veterinarians and pet owners alike and so we have produced an easy to follow guide as to how to go about the process.

Inhaled therapy guidelines

BreathEazy Divider

You May Also like

Effects and pharmacokinetics of nebulised lidocaine

Effects and pharmacokinetics of nebulised lidocaine

Background information Equine asthma treatment has traditionally always relied heavily on corticosteroids for effective treatment. However, there are a few limitations with corticosteroids – namely systemic usage has restrictions around competition and the increased...

read more
Airway Muscle Remodelling in Equine Asthma

Airway Muscle Remodelling in Equine Asthma

What is equine asthma? Equine asthma is a common clinical respiratory condition in the equine population, and it is especially common for horses to present to veterinary practices as mild or moderate cases. Many owners accept mild equine asthma signs as ‘normal’ in...

read more
BreathEazy Divider
Call Now Button